428 related articles for article (PubMed ID: 18539008)
1. Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia.
Poyraz BC; Aksoy C; Balcioğlu I
Eur Neuropsychopharmacol; 2008 Sep; 18(9):667-72. PubMed ID: 18539008
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic-induced hyperprolactinemia: a cross-sectional survey.
Johnsen E; Kroken RA; Abaza M; Olberg H; Jørgensen HA
J Clin Psychopharmacol; 2008 Dec; 28(6):686-90. PubMed ID: 19011438
[TBL] [Abstract][Full Text] [Related]
3. Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: effects on hyperprolactinemia.
Nakajima M; Terao T; Iwata N; Nakamura J
Pharmacopsychiatry; 2005 Jan; 38(1):17-9. PubMed ID: 15706461
[TBL] [Abstract][Full Text] [Related]
4. Hyperprolactinemia and Antipsychotic Therapy in Schizophrenic Patients with Hashimoto's Thyroiditis.
Sobolevskaia PA; Churilov LP; Fedotkina TV; Stepochkina A; Dolina A; Gvozdetckii AN; Andreev BV; Shoenfeld Y
Psychiatr Danub; 2021; 33(Suppl 4):1106-1112. PubMed ID: 35354176
[TBL] [Abstract][Full Text] [Related]
5. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
[TBL] [Abstract][Full Text] [Related]
6. Relationship between prolactin levels and subjective endocrine-related adverse effects in patients with schizophrenia receiving long-term treatment with amisulpride.
Kim EY; Kim SH; Lee NY; Jung DC; Kim YS; Ahn YM
Pharmacopsychiatry; 2012 Mar; 45(2):57-63. PubMed ID: 22411694
[TBL] [Abstract][Full Text] [Related]
7. Altered diurnal rhythm of prolactin in systemic sclerosis.
Hilty C; Brühlmann P; Sprott H; Gay RE; Michel BA; Gay S; Neidhart M
J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics.
Bushe C; Shaw M
J Psychopharmacol; 2007 Sep; 21(7):768-73. PubMed ID: 17606473
[TBL] [Abstract][Full Text] [Related]
9. Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone.
Lai YC; Chiou CC; Chen CH; Huang MC
J Clin Psychopharmacol; 2007 Oct; 27(5):523-4. PubMed ID: 17873693
[No Abstract] [Full Text] [Related]
10. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ
J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682
[TBL] [Abstract][Full Text] [Related]
11. Hyperprolactinaemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma.
Sayki Arslan M; Sahin M; Topaloglu O; Tutal E; Karakose M; Gungunes A; Cakal E; Ozbek M; Delibasi T
Clin Endocrinol (Oxf); 2013 Dec; 79(6):882-6. PubMed ID: 23551036
[TBL] [Abstract][Full Text] [Related]
12. Thyroid autoimmunity in patients with hyperprolactinemia: an observational study.
Onal ED; Saglam F; Sacikara M; Ersoy R; Cakir B
Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):48-52. PubMed ID: 24728164
[TBL] [Abstract][Full Text] [Related]
13. Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study.
Ganne-Carrie N; Medini A; Coderc E; Seror O; Christidis C; Grimbert S; Trinchet JC; Beaugrand M
J Autoimmun; 2000 Mar; 14(2):189-93. PubMed ID: 10677250
[TBL] [Abstract][Full Text] [Related]
14. Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases.
Akkaya C; Kaya B; Kotan Z; Sarandol A; Ersoy C; Kirli S
J Psychopharmacol; 2009 Aug; 23(6):723-6. PubMed ID: 18562408
[TBL] [Abstract][Full Text] [Related]
15. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
Leaños-Miranda A; Chávez-Rueda KA; Blanco-Favela F
Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic-induced hyperprolactinemia.
Bostwick JR; Guthrie SK; Ellingrod VL
Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
[TBL] [Abstract][Full Text] [Related]
17. Hyperprolactinemia in psychotic patients treated in monotherapy with long-acting injectable antipsychotics.
Bonete Llácer JM; Martínez Hortelano A; Richart Albelda B
Int J Psychiatry Clin Pract; 2019 Sep; 23(3):189-193. PubMed ID: 30848967
[No Abstract] [Full Text] [Related]
18. Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives.
Byerly M; Suppes T; Tran QV; Baker RA
J Clin Psychopharmacol; 2007 Dec; 27(6):639-61. PubMed ID: 18004132
[TBL] [Abstract][Full Text] [Related]
19. [An increased prevalence of thyroid echographic and autoimmune changes in hyperprolactinemic women on therapy with dopaminergic drugs].
Giusti M; Foppiani L; Fazzuoli L; Molinari E; Guido R; Valenti S; Giordano G
Recenti Prog Med; 1999 Mar; 90(3):147-51. PubMed ID: 10228354
[TBL] [Abstract][Full Text] [Related]
20. Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review.
De Hert M; Detraux J; Stubbs B
Expert Opin Drug Saf; 2016 Jun; 15(6):809-23. PubMed ID: 26986209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
